Kimberly Higginbotham Koenig

Statistics

Publications

Citations

120

H-Index

Active since

2014

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Kimberly Higginbotham Koenig is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and her2-positive metastatic disease.

Publications per year

2014–2021

Publications

Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study

Clinton Yam, Francisco J. Esteva, Miral Patel et al. · Investigational New Drugs · 2019 · 42 citations · Full text

Medicine, Oncology, Pharmacology +15

PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers

Ecaterina E. Dumbrava, S. Greg Call, Helen J. Huang et al. · ESMO Open · 2021 · 41 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2‐positive metastatic breast cancer

Rashmi K. Murthy, Ankur Varma, Priyankana Mishra et al. · Cancer · 2014 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

1–3 of 3